Relationship between parathyroid hormone and subclinical myocardial dysfunction in patients with severe psoriasis

Journal of the European Academy of Dermatology and Venereology

Volumn 28, Issue 4, 2014, Pages 461-468

  Zhao, C T ^a,b   Yeung, C K ^a   Siu, C W ^a,c   Tam, S ^d   Chan, J ^a   Chen, Y ^a   Chan, H H ^a   Tse, H F ^a,c   Yiu, K H ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b Traffic Hospital in Shan Dong Province   (China)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; METHOTREXATE; PARATHYROID HORMONE; TROPONIN I;

ADULT; ARTICLE; BLOOD LEVEL; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; HEART LEFT VENTRICLE FAILURE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PSORIASIS; TRANSTHORACIC ECHOCARDIOGRAPHY; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; BLOOD; CARDIOMYOPATHY; MIDDLE AGED; PATHOPHYSIOLOGY;

ADULT; CARDIOMYOPATHIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PARATHYROID HORMONE; PSORIASIS;

EID: 84899423586     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.12123     Document Type: Article

References (45)

1. National Psoriasis Foundation. About psoriasis. Statistics [WWW document]. 2007. URL http://www.psoriasis.org/about/stats/ (last accessed: 23 March 2007).
2. Griffiths CE, Barker JN,. Pathogenesis and clinical features of psoriasis. Lancet 2007. 370: 263-271.
3. Lowes MA, Bowcock AM, Krueger JG,. Pathogenesis and therapy of psoriasis. Nature 2007; 445: 866-873.
4. Ng AC, Delgado V, Bertini M, et al,. Findings from left ventricular strain and strain rate imaging in asymptomatic patients with type 2 diabetes mellitus. Am J Cardiol 2009; 104: 1398-1401.
5. McDonald CJ,. Cardiovascular disease in psoriasis. J Invest Dermatol 1989; 92: 646-647.
6. Wakkee M, Thio HB, Prens EP, et al,. Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients. Atherosclerosis 2007; 190: 1-9.
7. Singh VP, Le B, Khode R, Baker KM, Kumar R,. Intracellular angiotensin II production in diabetic rats is correlated with cardiomyocyte apoptosis, oxidative stress, and cardiac fibrosis. Diabetes Care 2008; 57: 3297-3306.
8. Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB,. Risk of myocardial infarction in patients with psoriasis. J Am Med Assoc 2006; 296: 1735-1741.
9. Ludwig RJ, Herzog C, Rostock A, et al,. Psoriasis: a possible risk factor for development of coronary artery calcification. Br J Dermatol 2007; 156: 271-276.
10. Mehta NN, Azfar RS, Shin DB, Neimann AL, Troxel AB, Gelfand JM,. Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database. Eur Heart J 2010; 31: 1000-1006.
11. Ahlehoff O, Gislason GH, Charlot M, et al,. Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study. J Intern Med 2011; 270: 147-157.
12. Brauchli YB, Jick SS, Miret M, Meier CR,. Psoriasis and risk of incident myocardial infarction, stroke or transient ischaemic attack: an inception cohort study with a nested case-control analysis. Br J Dermatol 2009; 160: 1048-1056.
13. Biyik I, Narin A, Bozok MA, Ergene O,. Echocardiographic and clinical abnormalities in patients with psoriasis. J Int Med Res 2006; 34: 632-639.
14. El-Mongy S, Fathy H, Abdelaziz A, et al,. Subclinical atherosclerosis in patients with chronic psoriasis: a potential association. J Eur Acad Dermatol Venereol 2010; 24: 661-666.
15. Melamed ML, Michos ED, Post W, Astor B,. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 2008; 168: 1629-1637.
16. Hagström E, Hellman P, Larsson TE, et al,. Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation 2009; 119: 2765-2771.
17. Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP,. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002; 110: 229-238.
18. Zhou C, Lu F, Cao K, Xu D, Goltzman D, Miao D,. Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1alpha-hydroxylase knockout mice. Kidney Int 2008; 74: 170-179.
19. Gisondi P, Rossini M, Di Cesare A, et al,. Vitamin D status in patients with chronic plaque psoriasis. Br J Dermatol 2012; 166: 505-510.
20. Regaña MS, Ezquerra GM, Millet PU,. Serum levels of parathyroid hormone and parathyroid-related peptide in psoriasis. Acta Derm Venereol 2005; 85: 420-423.
21. Lau KK, Chan YH, Yiu KH, et al,. Burden of carotid atherosclerosis in patients with stroke: relationships with circulating endothelial progenitor cells and hypertension. J Hum Hypertens 2007; 21: 445-451.
22. Chan YH, Lau KK, Yiu KH, et al,. Reduction of C-reactive protein with isoflavone supplement reverses endothelial dysfunction in patients with ischaemic stroke. Eur Heart J 2008; 29: 2800-2807.
23. Fredriksson T, Pettersson U,. Severe psoriasis-oral therapy with a new retinoid. Dermatology 1978; 157: 238-244.
24. Yiu YF, Chan YH, Yiu KH, et al,. Vitamin D deficiency is associated with depletion of circulating endothelial progenitor cells and endothelial dysfunction in patients with type 2 diabetes. J Clin Endocrinol Metab 2011; 96: E830-E835.
25. Lang RM, Bierig M, Devereux RB, et al,. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18: 1440-1463.
26. McQuillan BM, Picard MH, Leavitt M, Weyman AE,. Clinical correlates and reference intervals for pulmonary artery systolic pressure among echocardiographically normal subjects. Circulation 2001; 104: 2797-2802.
27. Nagueh SF, Appleton CP, Gillebert TC, et al,. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr 2009; 10: 165-193.
28. Delgado V, Ypenburg C, van Bommel RJ, et al,. Assessment of left ventricular dyssynchrony by speckle tracking strain imaging comparison between longitudinal, circumferential, and radial strain in cardiac resynchronization therapy. J Am Coll Cardiol 2008; 51: 1944-1952.
29. Eliakim-Raz N, Shuvy M, Lotan C, Planer D,. Psoriasis and dilated cardiomyopathy: coincidence or associated diseases? Cardiology 2008; 111: 202-206.
30. Prakash A, Deepshikha,. Psoriasis and cardiomyopathy: an intriguing association. Indian J Dermatol 2010; 55: 271-273.
31. Ulusoy R, Karabudak O, Yokusoglu M, Kilicaslan F, Kirilmaz A, Cebeci B,. Noninvasive assessment of impaired endothelial function in psoriasis. Rheumatol Int 2010; 30: 479-483.
32. Blessberger H, Binder T,. Two dimensional speckle tracking echocardiography: basic principles. Heart 2010; 96: 716-722.
33. Sitia S, Tomasoni L, Cicala S, et al,. Detection of preclinical impairment of myocardial function in rheumatoid arthritis patients with short disease duration by speckle tracking echocardiography. Int J Cardiol 2012; 160: 8-14.
34. Yiu KH, Schouffoer AA, Marsan NA, et al,. Left ventricular dysfunction assessed by speckle-tracking strain analysis in patients with systemic sclerosis: relationship to functional capacity and ventricular arrhythmias. Arthritis Rheum 2011; 63: 3969-3978.
35. Park CW, Oh YS, Shin YS, et al,. Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism. Am J Kidney Dis 1999; 33: 73-81.
36. Everett BM, Cook NR, Magnone MC, et al,. Sensitive cardiac troponin T assay and the risk of incident cardiovascular disease in women with and without diabetes mellitus: the Women's Health Study. Circulation 2011; 123: 2811-2818.
37. van den Hurk K, Alssema M, Kamp O, et al,. Slightly elevated B-type natriuretic peptide levels in a non-heart failure range indicate a worse left ventricular diastolic function in individuals with, as compared with individuals without, type 2 diabetes: the Hoorn Study. Eur J Heart Fail 2010; 12: 958-965.
38. Tomaschitz A, Ritz E, Pieske B, et al,. Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease. Cardiovasc Res 2012; 94: 10-19.
39. Asegaonkar SB, Marathe A, Tekade ML, et al,. High-sensitivity C-reactive protein: a novel cardiovascular risk predictor in type 2 diabetics with normal lipid profile. J Diabetes Complications 2011; 25: 368-370.
40. Tomaschitz A, Pilz S, Ritz E, et al,. Independent association between 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D and the renin-angiotensin system: the Ludwigshafen Risk and Cardiovascular Health (LURIC) study. Clin Chim Acta 2010; 411: 1354-1360.
41. Hsieh MC, Tien KJ, Chang SJ, et al,. High-sensitivity C-reactive protein and silent myocardial ischemia in Chinese with type 2 diabetes mellitus. Metabolism 2008; 57: 1533-1538.
42. Rahman A, Hershey S, Ahmed S, Nibbelink K, Simpson RU,. Heart extracellular matrix gene expression profile in the vitamin D receptor knockout mice. J Steriod Biochem Mol Biol 2007; 103: 416-419.
43. Ho SY,. Anatomy and myoarchitecture of the left ventricular wall in normal and in disease. Eur J Echocardiogr 2009; 10: iii3-iii7.
44. Ballo P, Quatrini I, Giacomin E, Motto A, Mondillo S,. Circumferential versus longitudinal systolic function in patients with hypertension: a nonlinear relation. J Am Soc Echocardiogr 2007; 20: 298-306.
45. van Hoeven KH, Factor SM,. A comparison of the pathological spectrum of hypertensive, diabetic, and hypertensive-diabetic heart disease. Circulation 1990; 82: 848-855.